Experimental browser for the Atmosphere
Loading post...
{ "uri": "at://did:plc:3h2rnhl4eqtoylezk6572ec2/app.bsky.feed.like/3lombsovas22p", "cid": "bafyreicavqjhcbbu3kjlcgpxgjs3ojf2hc6i6fsnxuveos464tue5wo2dy", "value": { "$type": "app.bsky.feed.like", "subject": { "cid": "bafyreigzmj54lze4nbershjeaayrnjgf5xic6o6dog67h4utrw5nl42syq", "uri": "at://did:plc:c66fwakiqz7f42sbcmtyiujk/app.bsky.feed.post/3lolo6fg4oc2g" }, "createdAt": "2025-05-07T20:54:43.448Z" } }
It's complicated. Several parts of the U.S. Code and CFR govern clinical trials and approval requirements for "new" drugs. This includes vaccines approved via BLAs. These laws describe different trial designs. But of course there's a ton of guidance. Still, "new" versus "not new" is important.
May 7, 2025, 3:03 PM